Skip to content

Implementation Science Webinar

Maridulu Budyari Gumal, the Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) Implementation Science Platform webinar recording.

The SPHERE Implementation Science Platform hosted an Implementation Science Webinar on 18th November 2020. The webinar was facilitated by Professor Chris Levi with an expert panel including Implementation Scientist Professor Sandy Middleton and Dr Caleb Ferguson and consumer representative Ainslie Cahill.

Three recipients of the Implementation Science seed funding grant presented their studies and offered valuable advice on designing implementation studies and tips for funding success.

The webinar is highly recommended for anyone responsible for leading translational work or interested in developing an implementation study.

The webinar was recorded and is available via the following link:

Access Passcode: PMb3K.SF

First 2000 Days Care Connect - Grant Success for ELDoH CAG

Congratulations to Maridulu Budyari Gumal Early Life Determinants of Health Clinical Academic Group ((ELDoH CAG) members Ms Tania Rimes and Associate Professor Sue Woolfenden (Chief Investigators) who were awarded $840,547 through the Translational Research Grants Scheme by the New South Wales Health for their project entitled 'First 2000 Days Care Connect'.

Early/mid-career cancer researchers awarded Cancer Clinical Academic Group seed grants

Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group has committed $100,000 in new seed grants for two interdisciplinary projects led by early/mid-career researchers (EMCRs) to be undertaken in 2021.

Congratulations to the successful awardees and their teams.

New liquid biopsies could provide hope for brain cancer patients

Increasing the efficacy of brain cancer treatment traditionally requires access to tissue samples that can shed light on a tumour’s genetic makeup. But, with many malignancies buried deep inside essential areas of the brain, this tissue is often impossible to reach.

A new research project led by Associate Professor Therese Becker of the Ingham Institute is aiming to solve this problem. Using ‘liquid biopsies’ – that is, blood tests – the researchers hope to reveal critical information about individual patient tumours.